Noriyuki Kasahara

Director, 4D Molecular Therapeutics, Inc.

Companies

4D Molecular Therapeutics, Inc.Board member Sep 27, 2022 to May 25, 2023¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAR4D Molecular Therapeutics, Inc., Board member